Factor Analysis
Volatility
Momentum
Value
Quality
Key Metrics
P/E
P/B
Div Yield
Price
Performance Returns Matrix
High volatility
Regular fluctuation
Weak month
Average
Decent year
Strong long-term
Excellent long-term
Technical Analysis
Quantitative Data Matrix & Analysis
Relative Strength Matrix & Analysis
Z-Score Charts
Seasonality Analysis
Corporate Actions & Events
Sign Up to View Full Analysis
Get access to performance matrices, advanced technical indicators, seasonality patterns, and historical event timelines.
Kilitch Drugs (India) Limited FAQs
Live market prices, valuation metrics, 52-week ranges, and financial information for Kilitch Drugs (India) Limited.
What is the share price of Kilitch Drugs (India) Limited today?
Kilitch Drugs (India) Limited share price today is ₹208.91. The stock is currently up by 3.35% from its previous close of ₹202.13. Today’s trading range is ₹202.01 to ₹210.60.
What is the 52-week high and low of Kilitch Drugs (India) Limited?
Kilitch Drugs (India) Limited’s 52-week high is ₹267.90 and its 52-week low is ₹117.25. At the current price of ₹208.91, the stock is 22.02% below its 52-week high and 78.17% above its 52-week low.
What is the market cap of Kilitch Drugs (India) Limited?
Kilitch Drugs (India) Limited has a market capitalisation of approximately ₹716.89 crore, based on its current share price and outstanding shares. It is classified as a micro-cap company.
What is the PE ratio and EPS of Kilitch Drugs (India) Limited?
Kilitch Drugs (India) Limited’s current P/E ratio is approximately 23.38x with an estimated trailing EPS of ₹8.94 per share.
What is the dividend yield of Kilitch Drugs (India) Limited?
Kilitch Drugs (India) Limited has a dividend yield of approximately 0.00% based on its latest dividend and current share price. The company paid an estimated dividend of ₹0.00 per share over the latest financial period.
What are the valuation metrics P/B and Price-to-Sales for Kilitch Drugs (India) Limited?
Kilitch Drugs (India) Limited currently trades at a Price-to-Book (P/B) ratio of 2.57x and a Price-to-Sales (P/S) ratio of 3.00x.